Skip to content
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer episode artwork

EPISODE · Aug 6, 2024 · 1H 15M

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

from Oncology Today with Dr Neil Love

Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Aug 6, 2024

Embed this episode

Ready to play

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

0:00 1:15:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 15 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on August 6, 2024.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!